Stevanato Group Spa

Stevanato Group is a global provider of drug containment, drug delivery, and engineering solutions to the pharmaceutical and biotechnology industries. The company operates through two segments: Biopharmaceutical and Diagnostic Solutions (BDS), which manufactures glass and plastic containment products including syringes, vials, and cartridges in both standard and ready-to-use (EZ-fill®) formats, as well as proprietary drug delivery devices such as the Alina® variable-dose pen and Deora™ fixed-dose pen injector; and Engineering, which designs and manufactures visual inspection machines, glass converting equipment, and assembly lines for drug delivery devices. Stevanato's strategy is focused on high-value solutions serving the biologics market, including GLP-1 therapies, monoclonal antibodies, and biosimilars. The company operates manufacturing facilities across Italy, the United States (Fishers, Indiana), Germany, Denmark, Brazil, and other locations, with key growth investments in its Fishers and Latina (Italy) plants. Its premium product portfolio includes Nexa® and Alba® syringes, EZ-fill® ready-to-use containment systems, and proprietary pen injector platforms. The company is listed on the New York Stock Exchange under the ticker STVN. Updated Aug 6, 2026